Search clinical trials for: RO5045337

Total 8 results

Hoffmann-La Roche

Completed

A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking Surgery

Sarcoma

France
Hoffmann-La Roche

Completed

A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.

Hematologic Neoplasms

United States, Canada, United Kingdom, Italy
Hoffmann-La Roche

Completed

A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors

Neoplasms

France, United States
Hoffmann-La Roche

Completed

A Study of RO5045337 in Patients With Solid Tumors

Neoplasms

United States
Hoffmann-La Roche

Completed

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Myelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, Acute

United States, France, Canada
Shimaa M. Abdelgawad

Completed

Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients

Covid19 | COVID-19 Respiratory Infection | Symptoms and Signs | Disseminated Intravascular Coagulation | COVID-19 Acute Bronchitis

Egypt
Hoffmann-La Roche

Completed

A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma

Sarcoma

France, United States
Hoffmann-La Roche

Completed

A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia

Myelogenous Leukemia, Acute

Canada, United States, United Kingdom, France, Italy

3

Subscribe